Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function
Status:
Completed
Trial end date:
2018-10-16
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the single-dose pharmacokinetics of
cilofexor in adults with impaired hepatic function relative to matched, healthy controls with
normal hepatic function.